BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20923118)

  • 1. [Pathogenesis of Pseudomonas aeruginosa infections].
    Cotar AI
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(4):139-45. PubMed ID: 20923118
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
    Döring G
    Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence factors of Pseudomonas aeruginosa.
    Döring G; Maier M; Müller E; Bibi Z; Tümmler B; Kharazmi A
    Antibiot Chemother (1971); 1987; 39():136-48. PubMed ID: 3118780
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].
    Döring G
    Infection; 1987; 15(1):47-50. PubMed ID: 3106228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
    Holder IA
    Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S; Tai PC
    Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
    [No Abstract]   [Full Text] [Related]  

  • 7. The contribution of diffusible toxins of Pseudomonas aeruginosa to the pathogenesis of experimental pyelonephritis.
    Al-Ssum RM; Harris DM
    J Infect; 1982 Jan; 4(1):49-55. PubMed ID: 6821099
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy.
    Stanislavsky ES; Dmitriev BA; Lányi B; Joó I
    Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant DNA approaches to the study of the regulation of virulence factors and epidemiology of Pseudomonas aeruginosa.
    Vasil ML; Ogle JW; Grant CC; Vasil AI
    Antibiot Chemother (1971); 1987; 39():264-78. PubMed ID: 3118789
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudomonas. Clinical problems related to virulence factors and development of resistance.
    Nordbring F
    Arch Intern Med; 1982 Oct; 142(11):2010-1. PubMed ID: 6812525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection.
    Sharma S; Kaur R; Yadav V; Harjai K; Joshi K
    Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B; Pavlovskis OR
    Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.
    Santajit S; Seesuay W; Mahasongkram K; Sookrung N; Ampawong S; Reamtong O; Diraphat P; Chaicumpa W; Indrawattana N
    Sci Rep; 2019 Oct; 9(1):14928. PubMed ID: 31624289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
    Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
    Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoxia Reduces the Pathogenicity of Pseudomonas aeruginosa by Decreasing the Expression of Multiple Virulence Factors.
    Schaible B; Rodriguez J; Garcia A; von Kriegsheim A; McClean S; Hickey C; Keogh CE; Brown E; Schaffer K; Broquet A; Taylor CT
    J Infect Dis; 2017 May; 215(9):1459-1467. PubMed ID: 28368464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.
    Sarac MS; Cameron A; Lindberg I
    Infect Immun; 2002 Dec; 70(12):7136-9. PubMed ID: 12438396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Pseudomonas aeruginosa extracellular enzymes in lung disease.
    Woods DE; Sokol PA
    Clin Invest Med; 1986; 9(2):108-12. PubMed ID: 3089661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carriage of the Pseudomonas aeruginosa virulence factors and prognosis after infection].
    Zhao RZ; Zheng YJ; Chen Q
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):672-7. PubMed ID: 23158816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and genetic studies of iron-regulated (exotoxin A) and phosphate-regulated (hemolysin phospholipase C) virulence factors of Pseudomonas aeruginosa.
    Vasil ML; Berka RM; Gray GL; Pavlovskis OR
    Antibiot Chemother (1971); 1985; 36():23-39. PubMed ID: 2988425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.